Oncopeptides AB (publ) (LON: 0RN4)
London
· Delayed Price · Currency is GBP · Price in SEK 1.344
-0.018 (-1.32%)
At close: Jan 21, 2025
Oncopeptides AB Revenue
Oncopeptides AB had revenue of 8.51M SEK in the quarter ending September 30, 2024, with 203.28% growth. This brings the company's revenue in the last twelve months to 27.07M, down -11.08% year-over-year. In the year 2023, Oncopeptides AB had annual revenue of 35.22M with 321.54% growth.
Revenue (ttm)
27.07M SEK
Revenue Growth
-11.08%
P/S Ratio
n/a
Revenue / Employee
474.93K SEK
Employees
57
Market Cap
21.22M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| Shell | 221.41B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| BP p.l.c. | 144.69B |
| British American Tobacco p.l.c. | 26.18B |